Sunovion Pharmaceuticals (SEPR) Inactive 10-K2002 FY Annual report

Filed: 31 Mar 03, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	8th grade Avg

New words: Abbreviated, abuse, accelerated, accidental, accrued, adult, Agent, allegedly, allocate, AMBIEN, AMP, ANDA, ASTELIN, average, azelastine, Book, borrowed, Canadian, capital, certainty, certify, certifying, challenging, characteristic, Coast, communicated, community, compromised, consumer, contamination, contrast, cumulative, cycle, database, derived, disclose, disclosed, discounted, disproportionate, disrupted, disseminated, earliest, elderly, electronically, eligible, ensure, EquiServe, exact, expansion, expedite, experience, exposed, fact, fail, false, faster, feeling, field, Foundation, fraud, fraudulent, free, full, funding, Guard, headcount, illegal, improper, income, increasingly, Indian, inflation, injury, inspection, insurance, internet, jet, Kingdom, knowingly, lag, likelihood, Locke, maintain, maintaining, meaningful, MedPointe, met, minimum, misleading, month, morning, natural, newly, Orange, order, outlined, outweigh, paid, percentage, PHS, physical, pipeline, Pond, poor, postmarketing, potency, practicable, profitable, prohibit, promulgated, purported, radioactive, rebate, recomputed, Reconciliation, referral, refractory, regular, reliance, remarkable, remuneration, rental, resume, role, safeguarded, scientific, SEC, Seprcor, shift, slightly, Solomon, SONATA, SPCC, strength, sublease, supervision, supplier, thereunder, transformed, unauthorized, undergoing, understood, unnecessary, unrefreshed, untrue, User, Valuation, variety, vasomotor, VHC, web, willingly, workforce

Removed: achieve, AG, aggregate, Alza, Andersen, antibacterial, area, Arthur, attempted, attention, attract, attracting, authorization, azamacrolide, bad, balance, BASF, capable, check, chemistry, ChiRex, combinatorial, Connecticut, credit, deficit, Delaware, delinquent, demonstrated, depending, discovered, dose, Employer, Endorex, enter, erectile, expand, expiratory, extend, financing, Fleet, fluoxetine, forced, granting, Groton, hauske, hyperactivity, ICE, Identification, Immunology, inhibitor, mark, Metabolic, nasdaq, obligated, Paul, personnel, pharmacoeconomic, pharmacology, pivotal, plant, project, rapidly, registered, relevant, retain, retaining, Revolving, rubin, screening, shorter, shown, skilled, statistically, team, telephone, terminated, trademark, transaction, voting, washington, worked, zileuton

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

SEPR similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 99.2

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the annual report on Form 10-K of Sepracor Inc. (the "Company") for the period ended December 31, 2002 as filed with the Securities and Exchange Commission on the date hereof (the "Report"), the undersigned, David P. Southwell, Chief Financial Officer of the Company, hereby certifies, pursuant to 18 U.S.C. Section 1350, that:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Dated: March 31, 2003
		/s/ DAVID P. SOUTHWELL David P. Southwell Chief Financial Officer

A signed original of this written statement required by Section 906 has been provided to Sepracor Inc. and will be retained by Sepracor Inc. and furnished to the Securities and Exchange Commission or its staff upon request.